Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
SLU-PP-332 is evaluated in laboratory research to study ERR receptor and energy expenditure pathway research
This gradual increase helps mitigate potential side effects like nausea while allowing the body to adjust to the medication
Tirzepatide activates receptors for glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), signaling the body to release insulin, lower blood sugar, and prevent the release of sugar-raising hormones
Availability and Access Without Insurance Barriers Brand-name semaglutide requires a prescription, and even with a valid Rx, supply chain limitations, insurance denials, and pharmacy inventory constraints often create access barriers
US$ 24.28
US$ 23.87
US$ 25.14
US$ 24.84
